Skip to main content
SpringerLink
Log in

SMC gives positive recommendations for eight drugs

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Scottish Medicines Consortium. SMC advice: apixaban (Eliquis); colecalciferol (Desunin); etanercept (Enbrel); ferumoxytol (Rienso); inhaled mannitol (Bronchitol); linagliptin (Trajenta); linagliptin+metformin (Jentadueto); palonosetron (Aloxi); ulipristal acetate (Esmya). Internet Document : 11 Feb 2013. Available from: URL: http://www.scottishmedicines.org.uk

Download references

Additional information

* all of who had an inadequate response to, or who have proved intolerant of, methotrexate or conventional therapy

Rights and permissions

Reprints and permissions

About this article

Cite this article

SMC gives positive recommendations for eight drugs. PharmacoEcon Outcomes News 672, 11 (2013). https://doi.org/10.1007/s40274-013-0188-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0188-x

Search

Navigation